-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Tango Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
- Tango Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $7.54M, a 47.2% increase year-over-year.
- Tango Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $24M, a 41.7% increase year-over-year.
- Tango Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.1M, a 34.1% increase from 2022.
- Tango Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.2M, a 81.7% increase from 2021.
- Tango Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.83M, a 344% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)